Published on 22/12/2025
“Requirements for Submitting Documents to the EC”
Introduction
Submitting a clinical study to an Ethics Committee (EC) is a crucial step in the research process. This submission involves a set of documents that must adhere to the quality standards and guidelines set by regulatory bodies. The EC meticulously reviews these documents to ensure the study’s ethical soundness and patient safety. This article will guide you through the essential document requirements for EC submission.
Investigator’s Brochure (IB)
The Investigator’s Brochure (IB) is a compilation of the clinical and non-clinical data about the investigational product. It’s necessary for the investigator’s understanding of the product and should be included in the EC submission. For guidance on creating an IB, refer to the ICH guidelines for pharmaceuticals.
Protocol and Protocol Amendments
A detailed protocol outlining the study design, objectives, methodology, statistical considerations, and organization is required. Any amendments to the protocol should also be included in the submission. The Pharmaceutical SOP guidelines can provide valuable insights into creating a robust protocol.
Informed Consent Form (ICF) and Patient Information Sheet (PIS)
The ICF and PIS are critical documents that ensure the patient’s informed consent. They should be written
Investigator’s CV and GMP Certification
The investigator’s CV is required to demonstrate their competence and experience in conducting clinical studies. Moreover, the investigator should provide proof of GMP certification, ensuring their knowledge of good manufacturing practices that guarantee the quality of the investigational product.
Insurance Certificate
An insurance certificate is necessary to demonstrate that adequate compensation measures are in place in the event of any injury or adverse event to the study participants. Ensure that you have an appropriate insurance cover for your study.
Stability Information
The EC should be provided with stability information about the investigational product. This includes the product’s shelf-life and storage conditions. For more guidelines on stability information, refer to the ICH stability guidelines.
Validation Master Plan
The Validation Master Plan outlines the approach to the validation of the processes, systems, and methods used in the study. It’s a critical document demonstrating the study’s reliability and consistency. For help in preparing this plan, refer to the Validation master plan pharma.
Additional Documents
Depending on the nature and scope of the study, additional documents such as lab accreditation certificates, data management plan, and safety monitoring plan may also be required. It’s recommended to consult with a Regulatory affairs career in pharma for comprehensive guidance.
Conclusion
Preparing for an EC submission requires careful attention to the completeness and quality of the required documents. Adherence to guidelines such as those provided by Health Canada can ensure a smooth submission process and increase the chances of approval. Remember, the ultimate goal is to ensure the safety and protection of the study participants.